In their editorial, Drs. Bourdette and Whitham1 mentioned "avoiding use of repository corticotropin (Acthar gel) to treat MS relapses." Objectively considering H.P. Acthar Gel, the only Food and Drug Administration–approved noncorticosteroid therapy option for multiple sclerosis (MS) relapse, as a treatment option is in the best interest of patients.
from # All Medicine by Alexandros G. Sfakianakis via alkiviadis.1961 on Inoreader http://ift.tt/2weObKY
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.